Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
about
SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer.SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization.Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancerExpression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis.The expression profile and clinic significance of the SIX family in non-small cell lung cancerIntegrated bioinformatics analysis of miRNA expression in osteosarcoma.Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members.The Homeotic Protein SIX3 Suppresses Carcinogenesis and Metastasis through Recruiting the LSD1/NuRD(MTA3) Complex.A novel long noncoding RNA lncWDR26 suppresses the growth and metastasis of hepatocellular carcinoma cells through interaction with SIX3.
P2860
Q33750953-6CC43BF8-754B-480E-9E12-FB82419555C0Q33781657-D12CE135-ADAE-443B-A98E-5371E4740475Q36097570-4DAA0843-AF0E-4960-A3B4-772A91AEFB8EQ36566682-52A1B27D-5456-4129-B8B0-1BA66D0E00F5Q37328021-FC963ABE-C539-4B41-89F4-374553347279Q37400801-CFC9EB03-289F-4E44-8FC5-EA785EC9E48CQ39674902-9B0D6A43-E734-41D4-9DAB-183A8A550237Q48227731-0D4D96B9-CE15-4D31-996F-B90BC8322F9FQ49788159-F5F4EFFA-2566-4CD9-BCC8-2B40DB62BBCFQ55002362-BF865B3B-65B6-4C21-8F67-C1650A81F913
P2860
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@ast
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@en
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@nl
type
label
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@ast
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@en
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@nl
prefLabel
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@ast
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@en
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@nl
P2093
P2860
P1433
P1476
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma
@en
P2093
David M Jablons
Geneviève Bosco-Clément
Hai-Meng Zhou
Iwao Mikami
Junichi Okamoto
Tomomi Hirata
P2860
P304
P356
10.1371/JOURNAL.PONE.0071816
P407
P577
2013-08-16T00:00:00Z